Exercise

Press release - “Parliament 2024”: a more modern and efficient Parliament after the elections

Retrieved on: 
星期四, 四月 18, 2024
Emergency, Parliament, Conference, Exercise, EPP, European Parliament, Framework agreement, Committee, Policy, House, Commission, Council, EP, TFEU, Legislation

The new internal rules will strengthen Parliament’s working methods, its institutional role, and its capacity to act.Committee on Constitutional Affairs Source : © European Union, 2024 - EP

Key Points: 


The new internal rules will strengthen Parliament’s working methods, its institutional role, and its capacity to act.Committee on Constitutional Affairs Source : © European Union, 2024 - EP

Orphan designation: (6aR,10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid- Treatment of cystic fibrosis, 14/10/2016 Withdrawn

Retrieved on: 
星期四, 四月 18, 2024
Eurostat, Diagnosis, Civil service commission, Absorption, Lower respiratory tract infection, Exercise, Cell, Infection, DSM-IV codes, Inflammation, Patient, Committee, Cystic fibrosis, Knowledge, Digestion, Regulation, Bacteria, Food, EMA, IRIS, Anti-inflammatory, Mucus, CB2, European, COMP, Pancreas, Sponsor, Ivacaftor, European Commission, Safety, CFTR, Marketing, Medicine, Pharmaceutical industry

Orphan designation: (6aR,10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid- Treatment of cystic fibrosis, 14/10/2016 Withdrawn

Key Points: 


Orphan designation: (6aR,10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid- Treatment of cystic fibrosis, 14/10/2016 Withdrawn

Philip R. Lane: Disinflation in the euro area: an update

Retrieved on: 
星期四, 四月 18, 2024
Element, Reproduction, SAFE, Speech, Conference, Growth, Brookings Institution, Disinflation, Finance, Projection, Exercise, ECB, Real, Risk, Frankfurt, Bank, SPF, Policy, Communication, ILS, HICP, OIS, DFR, GDP, The, APP, Watcher, Bangladesh Technical Education Board, Probability, Swings, Fiscal, Acceleration, Goethe University Frankfurt, Personal ordinariate, PEPP, CTS, European Central Bank, Fear, Bookkeeping

Stock market development and familiarity (language and distance) are considered key determinants for home bias.

Key Points: 
  • Stock market development and familiarity (language and distance) are considered key determinants for home bias.
  • The literature neglects however that investors often invest in foreign funds domiciled in financial centers.

Isabel Schnabel: The future of inflation (forecast) targeting

Retrieved on: 
星期四, 四月 18, 2024
Reproduction, Exercise, Finance, Journal of Economic Perspectives, Calibration, Frankfurt, Empirical evidence, American Economic Association, Great Moderation, Interest, Inflation, Norges Bank, Policy, Bank, The Economic Journal, Speech, Employment, ECB, Risk, University of Chicago Press, Communication, Sveriges Riksbank, Debate, OECD, European Economic Review, Watcher, Economic Policy (journal), Goethe University Frankfurt, Federal Reserve Bank, Depression, Christian Social Union (UK), Climate change, Projection, IPhone, Intelligence, Agriculture, Bias, Journal, Research, Disinflation, Harvard Business School, University, Food, Business cycle, Bank of England, European Central Bank, The, American Economic Journal, Uncertainty, Attention, Finance Secretary (India), Conference, Forecasting, Growth, Rotation, Environment, Reserve Bank, Federal, COVID-19, Washington, D.C., Metal, HICP, Federal Reserve, Working paper, American Economic Review, Cryptocurrency

Stock market development and familiarity (language and distance) are considered key determinants for home bias.

Key Points: 
  • Stock market development and familiarity (language and distance) are considered key determinants for home bias.
  • The literature neglects however that investors often invest in foreign funds domiciled in financial centers.

Transactional demand for central bank digital currency

Retrieved on: 
星期四, 四月 18, 2024
POS, Learning, CB, E41, Calibration, Financial regulation, Interest, ATM, Oesterreichische Nationalbank, Journal of Macroeconomics, Sensitivity, Diffusion, ITunes, Bank of Canada, P2P, Safety, NBER, Benchmarking, Prevalence, SPACE, Bernoulli, Journal of Monetary Economics, E42, Paper, European Parliamentary Research Service, Apollo, Environment, Political economy, COVID-19, Review of Economic Dynamics, Abramov, Loss, Working paper, Choice, Collection, Probability, Dowd, Castrén, Face, Noise, History, Restaurant, Journal of Political Economy, ECB, Policy, Diary, Model, Utility, Clutch (eggs), Canadian International Council, Journal of Financial Stability, JEL, Digital, Bias, Journal, Research, Classification, CBDC, SARS-CoV-2, ECMI, Credit, Odds ratio, Literature, European Central Bank, Mises Institute, Monetary economics, Section 5, Occupation, E47, Financial intermediary, Government, Supermarket, Friction, Finance, BIS, Love, Bart, The Economic Journal, Education, Risk, Section 4, Privacy, Section 3, Appetite, App Store (iOS/iPadOS), Human, DNB, International finance, Section 2, Leonhard Euler, Payment, Attention, Central bank, Consumer, EPRS, Habit, American Economic Review, Confidence interval, FCO, Central bank digital currency, Exercise, Letizia, Applied economics, Digital currency, Sale, Business cycle, Amazon, Community business development corporation, Control, Chart, Proxy, American Economic Journal, LN, Bank, Fintech, IMF, Analysis, Aggregation, Cryptocurrency
Key Points: 

    Feedback on the input provided by the European Parliament as part of its resolution on the ECB’s Annual Report 2022

    Retrieved on: 
    星期四, 四月 18, 2024
    Crypto, European banking union, Governance, Exercise, TARGET, Ciccarelli, Single, Climate, OJ, Ethics, Carbon, ECRB, Parliament, Council, European Systemic Risk Board, European Commission, Paris Agreement, Television, Annual, Letter, Speech, Employment, Social, ESRB, Euro, Prejudice, FSB, AML, ECB, Blog, Risk, ESCB, Committee, NGFS, Policy, Woman, Suggestion, Radio, GDP, Privacy, Weather, Person, Climate change, Communication, Digital, Intelligence, Economic and monetary union, SSM, Bias, Knowledge, Mentorship, EMU, Commission, Economy, Publication, Annual report, Financial Action Task Force, Orientation, Nickel, NPL, European Central Bank, Uncertainty, Financial Stability Board, Conference, NCBS, Treaty, Growth, Financial system, Central bank, European Parliament, Network, Natural Resources, COVID-19, Terrorism, Bank, Female, IMF, Multi-function printer, Recreation, Memorandum, Data, AMLA, Security printing

    Beyond managing related risks, the financial sector can also contribute to the transition toward a net-zero economy.

    Key Points: 
    • Beyond managing related risks, the financial sector can also contribute to the transition toward a net-zero economy.
    • Our work aims to enhance data transparency in climate change analysis, while informing monetary policy, financial stability and banking supervision.
    • The indicators we have developed focus on the euro area financial sector and are built from harmonised granular datasets.

    ESAs to run voluntary dry run exercise to prepare industry for the next stage of DORA implementation

    Retrieved on: 
    星期四, 四月 18, 2024
    EBA, Workshop, ESMA, Digital, EIOPA, Collection, Exercise, ICT, Security (finance)

    ESAs to run voluntary dry run exercise to prepare industry for the next stage of DORA implementation

    Key Points: 
    • ESAs to run voluntary dry run exercise to prepare industry for the next stage of DORA implementation
      The European Supervisory Authorities (EBA, EIOPA and ESMA – the ESAs) today announced that they will launch in May the voluntary exercise for the collection of the registers of information of contractual arrangements on the use of ICT third-party service providers by the financial entities.
    • Under the Digital Operation Resilience Act (DORA) and starting from 2025, financial entities will have to maintain registers of information regarding their use of ICT third-party providers.
    • In this dry run exercise, this information will be collected from financial entities through their competent authorities and will serve as preparation for the implementation and reporting of registers of information under DORA.
    • Workshop
      To provide more information regarding the dry run exercise, the ESAs invite financial entities to take part in an introductory workshop on 30 April 2024 from 10:00 to 12:00.

    No, taking drugs like Ozempic isn’t ‘cheating’ at weight loss or the ‘easy way out’

    Retrieved on: 
    星期三, 四月 10, 2024
    Eating, Reward, Diarrhea, Cardiovascular disease, Obesity, Exercise, Therapeutic Goods Administration, Cell, Hunger, Energy, Half-life, Indigestion, Abdominal pain, Gardening, Insulin, Risk, Diabetes, Weight loss, Stroke, Constipation, Research, Food, Meal, Pharmaceutical Benefits Scheme, Diet, Nausea, Gallbladder disease, Dance, Kidney failure, Hypoglycemia, TGA, BMI, Vomiting, Acute pancreatitis, STEP, Pharmaceutical industry

    Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight.

    Key Points: 
    • Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight.
    • As demand for semaglutide increases, so are claims that taking it is “cheating” at weight loss or the “easy way out”.
    • We don’t tell people who need statin medication to treat high cholesterol or drugs to manage high blood pressure they’re cheating or taking the easy way out.

    How does it work?

    • GLP-1 gets secreted by cells in your gut when it detects increased nutrient levels after eating.
    • GLP-1 receptor agonist (GLP-1RA) medications like Ozempic help the body’s own GLP-1 work better by mimicking and extending its action.
    • Read more:
      The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs

    What can users expect? What does the research say?

    • Higher doses of semaglutide are prescribed to treat obesity compared to type 2 diabetes management (up to 2.4mg versus 2.0mg weekly).
    • A large group of randomised controlled trials, called STEP trials, all tested weekly 2.4mg semaglutide injections versus different interventions or placebo drugs.
    • Trials lasting 1.3–2 years consistently found weekly 2.4 mg semaglutide injections led to 6–12% greater weight loss compared to placebo or alternative interventions.
    • Weight reduction due to semaglutide also leads to a reduction in systolic and diastolic blood pressure of about 4.8 mmHg and 2.5 mmHg respectively, a reduction in triglyceride levels (a type of blood fat) and improved physical function.
    • Another recent trial in adults with pre-existing heart disease and obesity, but without type 2 diabetes, found adults receiving weekly 2.4mg semaglutide injections had a 20% lower risk of specific cardiovascular events, including having a non-fatal heart attack, a stroke or dying from cardiovascular disease, after three years follow-up.

    Who is eligible for semaglutide?

    • Australia’s regulator, the Therapeutic Goods Administration (TGA), has approved semaglutide, sold as Ozempic, for treating type 2 diabetes.
    • The TGA has approved Wegovy to treat obesity but it’s not currently available in Australia.

    What else do you need to do during Ozempic treatment?

    • In addition to taking medication, people had brief lifestyle counselling sessions with dietitians or other health professionals every four weeks as a minimum in most trials.
    • The aim of these trials was to show the effect of adding the medication on top of other lifestyle counselling.


    A review of obesity medication trials found people reported they needed less cognitive behaviour training to help them stick with the reduced energy intake. This is one aspect where drug treatment may make adherence a little easier. Not feeling as hungry and having environmental food cues “switched off” may mean less support is required for goal-setting, self-monitoring food intake and avoiding things that trigger eating.

    But what are the side effects?

    • In on study these led to discontinuation of medication in 6% of people, but interestingly also in 3% of people taking placebos.
    • More severe side-effects included gallbladder disease, acute pancreatitis, hypoglycaemia, acute kidney disease and injection site reactions.
    • Here are some potential risks and benefits

      To reduce risk or severity of side-effects, medication doses are increased very slowly over months.

    • Health, Meat and Livestock Australia, and Greater Charitable Foundation.
    • She has consulted to SHINE Australia, Novo Nordisk, Quality Bakers, the Sax Institute, Dietitians Australia and the ABC.

    Holding(s) in Company

    Retrieved on: 
    星期三, 四月 10, 2024
    Vii, Central Bank of Myanmar, Letter, Central bank, Exercise, Acquisition, Person, Disclosure, Life, LEI, Ix, Legislation, Security (finance)

    Any personal data will be processed in accordance with the requirements of data protection legislation.

    Key Points: 
    • Any personal data will be processed in accordance with the requirements of data protection legislation.
    • Any queries concerning the processing of personal data by the Central Bank may be directed to [email protected] .
    • iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g.
    • v Applicable in the cases provided for in Regulation 15(b) to (h) of the Regulations (Article 10 (b) to (h) of Directive 2004/109/EC).

    Shareholders approve all proposals at Extraordinary General Meeting

    Retrieved on: 
    星期三, 四月 10, 2024
    EUR, Exercise, CHF, Security (finance)

    At the Extraordinary General Meeting held today, Swiss Steel Group's shareholders have approved the ordinary capital increase proposed by the Board of Directors for the purpose of continuing the restructuring of Swiss Steel Group.

    Key Points: 
    • At the Extraordinary General Meeting held today, Swiss Steel Group's shareholders have approved the ordinary capital increase proposed by the Board of Directors for the purpose of continuing the restructuring of Swiss Steel Group.
    • The capital increase will consist of the issuance of 3,101,000,000 fully paid-up registered shares at an issue price of CHF 0.0925 each.
    • The capital increase was approved by shareholders with 99.79 % of the votes represented.
    • The Chairman Jens Alder states: “I am grateful for the patience and the trust we have received from our shareholders.